ViroPharma expands in PA, creates 151 jobs

Tuesday, September 11, 2012 08:00 AM

ViroPharma, a biopharmaceutical company that focuses on rare diseases, will expand its operations in Exton, Penn., and create 151 new, high-paying jobs.

"ViroPharma is a true Pennsylvania success that continues to grow and create jobs in the region," said Tom Corbett, governor of Pennsylania. "What started as a small team of entrepreneurs in Exton has now evolved into an international biopharmaceutical company employing hundreds of Pennsylvanians."

ViroPharma will nearly double its current available space by leasing an additional 71,000 square feet of office space to accommodate planned growth. The expansion will enable the company to retain its existing 188 employees and create at least 151 new jobs within three years.

The company received a $583,000 funding offer from the Department of Community and Economic Development, including a $130,000 Pennsylvania First grant and $453,000 in Job Creation Tax Credits. 

"For us it is about growth. ViroPharma has been in Exton for many years and we love our home here," said Vincent J. Milano, president and CEO of ViroPharma. "We're committed to this area for the long-term and look forward to creating opportunities in this community."

Share:          
CWWeekly

February 23

Venture capital investors funding novel drug R&D three times more than companies repurposing, improving existing drugs

In appreciation: Karen Woodin will be remembered for her teaching, writing and lasting friendships

Already a subscriber?
Log in to your digital subscription.

Subscribe to CWWeekly.

The CenterWatch Monthly

February

Study grants market breaks $13 billion
Volume of clinical activity rising while growth in grant spending slows

Revisiting eClinical Technology Solutions Adoption
While use of established solutions grows, sponsors hesitate on newer tools

Already a subscriber?
Log in to your digital subscription.

Purchase the February issue.

Subscribe to
The CenterWatch Monthly.

The CenterWatch Monthly

January

All eyes on EMA’s adaptive licensing pilot
Sponsors could offer innovative drugs to patients 8 years sooner

Ice Bucket Challenge a boon for ALS research
Donations soar, but phenomenon difficult to replicate

Already a subscriber?
Log in to your digital subscription.

Purchase the January issue.

Subscribe to
The CenterWatch Monthly.

JobWatch centerwatch.com/jobwatch

Featured Jobs